Medpace
MEDP
207 hedge funds and large institutions have $1.47B invested in Medpace in 2018 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 77 increasing their positions, 39 reducing their positions, and 17 closing their positions.
371% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 17
140% more capital invested
Capital invested by funds: $612M → $1.47B (+$859M)
97% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 39
49% more call options, than puts
Call options by funds: $5.91M | Put options by funds: $3.95M
44% more funds holding
Funds holding: 144 → 207 (+63)
28.92% more ownership
Funds ownership: 40.06% → 68.97% (+29%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$61.6M |
| 2 |
BlackRock
New York
|
+$37M |
| 3 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$34M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$32.9M |
| 5 |
Renaissance Technologies
New York
|
+$24.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$12.4M |
| 2 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$11.2M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
-$7.25M |
| 4 |
Janus Henderson Group
London,
|
-$4.33M |
| 5 |
BCA
Bernzott Capital Advisors
Camarillo,
California
|
-$3.69M |
MEDP Hedge Fund Activity: Q3 2018 in Review
207 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q3 2018, worth a combined $1.47B — up 140% from $612M a quarter earlier.
Buyers outnumbered sellers: 80 funds opened new MEDP positions and 17 closed out — a net gain of 63 holders — while 77 added to existing stakes and 39 trimmed.
The largest buyer was Vanguard Group, adding an estimated $61.6M. The largest seller was UBS Group, cutting an estimated $12.4M.
- 207 institutional investors held Medpace (MEDP) as of Q3 2018, up from 144 in Q2 2018.
- Funds reported $1.47B of Medpace stock for Q3 2018, up 140% quarter-over-quarter.
- 80 funds opened new Medpace positions in Q3 2018 and 17 closed out, a net change of +63 holders.
- The largest Medpace buyer in Q3 2018 was Vanguard Group, an estimated $61.6M added.
- The largest Medpace seller in Q3 2018 was UBS Group, an estimated $12.4M sold.
Based on aggregated 13F filings for Q3 2018.